Please sign in to follow a disease.
Hypopituitarism
MONDO:0005152A condition of diminution or cessation of secretion of one or more hormones from the anterior pituitary gland. This may result from surgical or radiation ablation, non-secretory pituitary neoplasms, metastatic tumors, infarction, pituitary apoplexy, infiltrative or granulomatous processes, and other conditions.
Also known as: pituitary insufficiency
47 clinical trials for this condition and its sub-types, 5 tagged with Hypopituitarism itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Part of
Sub-types of Hypopituitarism
-
Combined pituitary hormone deficiencies, genetic form 1 trial · 42 incl. sub-types
9 sub-types
- Isolated congenital growth hormone deficiency 38 trials Sub-types →
- Panhypopituitarism 2 trials Sub-types →
- Congenital isolated adrenocorticotropic hormone deficiency 1 trial
- Pituitary hormone deficiency, combined, 1 1 trial
- Septooptic dysplasia 1 trial Sub-types →
- Non-acquired combined pituitary hormone deficiency with spine abnormalities 0 trials
- Pituitary hormone deficiency, combined or isolated, 8 0 trials
- Pituitary hormone deficiency, combined, 6 0 trials
- Short stature-pituitary and cerebellar defects-small sella turcica syndrome 0 trials
-
Acquired pituitary hormone deficiency 0 trials · 1 incl. sub-types
4 sub-types
- Pituitary apoplexy 1 trial
- Iatrogenic or traumatic pituitary deficiency 0 trials
- Late-onset isolated ACTH deficiency 0 trials
- Primary hypophysitis 0 trials Sub-types →
-
Kaplowitz-Bodurtha syndrome 0 trials
Most studied deeper sub-types
-
Daily pill may replace growth hormone shots for children
Disease control Not yet recruitingThis study evaluates the long-term safety of an oral medication called LUM-201 for children with growth hormone deficiency (GHD). Children who completed a prior 12-month trial can receive LUM-201 daily for up to 36 additional months. The goal is to see if the pill is safe and tol…
Phase 3 • Sponsor: Lumos Pharma • Aim: Disease control
Last updated Jul 10, 2026 00:00 UTC
-
New Long-Acting growth hormone shot could mean fewer needles for kids
Disease control Not yet recruitingThis study tests a new medicine called GenSci134, a long-acting growth hormone, in 128 children with growth hormone deficiency (GHD). The goal is to find the best dose and see if it is safe and helps children grow taller. In the first part, children get one shot of GenSci134; in …
Phase 1/2 • Sponsor: Changchun GeneScience Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 09:11 UTC
-
300 belgian kids to help unlock growth Hormone's metabolic secrets
Knowledge-focused Not yet recruitingThis study will follow 300 Belgian children with growth hormone deficiency for three years to see how their bodies respond to daily or weekly growth hormone shots. Researchers will measure growth, weight, blood sugar, fats, and other health markers. The goal is to understand whic…
Sponsor: Cliniques universitaires Saint-Luc- Université Catholique de Louvain • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:31 UTC